ALLE:NYSEAllegion plc Analysis

The stock is trading at $147.53, well below its 20‑day SMA of $161.86 and the 50‑day SMA of $163.89, indicating a technical lag. Yet the 14‑day RSI sits at 28.5, placing the shares in oversold territory and suggesting a potential short‑term rebound. The MACD line remains negative at –4.52 and is below the signal line, reinforcing a bearish momentum in the near term. Volatility is elevated at roughly 36.8% over the past 30 days, while the beta of 0.64 points to lower systematic risk than the broader market. On the fundamentals side, revenue grew 7.8% YoY to $4.07 bn and operating margin expanded to 21.1%, underscoring solid top‑line momentum.
Valuation metrics show a trailing P/E of 19.8, substantially below the industry average of 29.4, and a forward P/E of 15.6, implying relative cheapness despite the current price exceeding the DCF‑derived fair value of $100.3. The dividend yield of 1.41% is supported by a modest payout ratio of 27% and robust free cash flow of $505 m, indicating sustainability. However, the balance sheet carries a debt‑to‑equity of 104%, which, while high, is offset by strong cash generation and a ROE of 36%. Overall, the stock sits at a crossroads where technical weakness meets fundamentally sound growth, offering upside to the consensus target of $176.